Resources

3 Resources for

david rau

Time to Buy ImmunoGen: David Rau submits: With the overall stock market and the economy in shambles, is it time to start looking at beaten-down biotechs for large percentage moves. My choice for huge upside growth is ImmunoGen IMGN. As many know, Genentech DNA recently announced that trastuzumab-dm1 will enter a pivotal...; Tags: Biotech, David Rau, ImmunoGen Inc.; External links 2008-12-04
Genentech's Trastuzumab-Dm1 Shows Great Promise in Treating Breast Cancer: David Rau submits: Now that the SABC San Antonio Breast Cancer Conference is over, and the new year is upon us, what have we learned. Genentech DNA just announced data for the most promising oncology product in its pipeline, Trastuzumab-Dm1, or TDM-1. TDM-1 is a next generation treatment for Metastatic...; Tags: Biotech, Healthcare, David Rau, Genentech Inc., ImmunoGen Inc.; External links 2009-01-06
Immunogen: Moving on Up: David Rau submits: As evidenced by the volume of shares traded, [[IMGN]] still has not caught the fancy of investors or traders of substance. IMGN has moved up smartly from month ago lows of 4 dollars and is now trading in the $7 range. The volume remains around...; Tags: Biotech, David Rau, Genentech Inc., ImmunoGen Inc.; External links 2009-03-27

EarthLink, Motorola Executives and David S. Isenberg to Deliver Keynotes at ISPCON Spring 2006; Experts to Provide Insight into Today's Hot Topics Including Net Neutrality, Municipal Networks and Competitive Challenges: BALTIMORE -- Today, The Golden Group announced the roster of keynote speakers for ISPCON Spring 2006, the leading event for wired and wireless ISPs. Presenters will include: Donald B. Berryman, EVP/president Municipal Networks for EarthLink Inc.; David S. Isenberg, principal, isen.com; and Raghu Rau, SVP Global Marketing and Strategy for...; Tags: EarthLink Inc., Motorola Inc.; Research articles 2006-03-23